Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 66

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 66
---
ige Consumer Healthcare Inc., 660 White Plains Road, Tarrytown, New York 10591, Attention: Corporate Secretary, at least two weeks before the meeting.

| 74 |     | 2025 Proxy Statement | Prestige Consumer Healthcare Inc. |

Information About the Annual Meeting

What is Prestige Consumer Healthcare and where is it located? Prestige Consumer Healthcare Inc. is a holding company incorporated under the laws of the State of Delaware that, through its wholly owned subsidiaries, markets and distributes well-recognized, brand name over-the-counter healthcare products throughout the U.S. and Canada, and in certain international markets. Major brands include Monistat®, Nix®, Chloraseptic®, Clear Eyes®, Compound W®, DenTek®, Luden’s®, Dramamine®, BC®, Goody’s®, TheraTears®, Debrox®, Fleet®, Summer’s Eve®, Boudreaux’s Butt Paste®, Hydralyte®, Fess®, as well as Gaviscon® in Canada. Our principal executive offices are located at 660 White Plains Road, Tarrytown, New York 10591. Our telephone number is (800) 831-7105. Where is our common stock traded? Our common stock is traded and quoted on the NYSE under the symbol “PBH.” Voting Matters

| Proposal |                                                                                                                                                                                                              |                                               | Board’sRecommendation   | See Page |
| 1        | To elect the seven directors nominated by the Board of Directors and named in thisProxy Statement to serve until the 2026 Annual Meeting of Stockholders or until theirearlier death, removal or resignation |                                               | FOReachdirector nominee |       13 |
|          | •Ronald M. Lombardi•John E. Byom•Celeste A. Clark•James C. D’Arecca                                                                                                                                          | •Sheila A. Hopkins•John F. Kelly•Dawn M. Zier |                         |          |
| 2        | To vote on a non-binding resolution to approve the compensation of our namedexecutive officers as disclosed in our Proxy Statement                                                                           |                                               | FOR                     |       39 |
| 3        | To ratify the appointment of PricewaterhouseCoopers LLP as the independentregistered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal yearending March 31, 2026                    |                                               | FOR                     |       67 |

Who is entitled to vote? You may vote if you owned shares of our common stock at the close